Physician profile
Rene A Lee Pack
NPI 1851358766
$13,065.42
in general payments reported to CMS, 2019-2025
48 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $1,003 · 2021: $2,133 · 2022: $2,319 · 2023: $2,674 · 2024: $2,425 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,427.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,476.35 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,397.78 | 2019-2025 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $1,370.23 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $1,349.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,100.66 | 2019-2025 | |
| Abbvie INC. | $1,077.38 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,058.39 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $1,023.19 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $387.83 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $279.06 | 2020-2025 | Repatha, Otezla, Prolia |
| Amarin Pharma, INC. | $233.18 | 2020-2022 | |
| Exact Sciences Corporation | $223.06 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $172.35 | 2021-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $147.72 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.77 | 2022-2024 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Lee Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.